BMJ Open (Apr 2022)
Using routine healthcare data to evaluate the impact of the Medicines at Transitions Intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilot
- Chris Gale,
- Beth Fylan,
- Hanif Ismail,
- Liz Breen,
- Peter Gardner,
- Sarah Alderson,
- Amanda Farrin,
- Catherine Powell,
- Andrew Taylor,
- Suzanne Hartley,
- Chris Bojke,
- Ivana Holloway,
- David Phillip Alldred,
- Jonathan Silcock,
- Lauren A Moreau,
- Bonnie Cundill,
- Alison Fergusson,
- Ellen Mason
Affiliations
- Chris Gale
- 4 Neonatal Medicine, School of Public Health, Faculty of Medicine, Imperial College London, London, UK
- Beth Fylan
- 1 School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK
- Hanif Ismail
- 1 School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK
- Liz Breen
- 1 School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK
- Peter Gardner
- 2 Wolfson Centre for Applied Health Research, Bradford, UK
- Sarah Alderson
- Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
- Amanda Farrin
- Complex Interventions Division, Clinical Trial Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
- Catherine Powell
- School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Bradford, UK
- Andrew Taylor
- Alder Hey Children’s Hospital
- Suzanne Hartley
- Clinical Trials Research Unit (CTRU), University of Leeds, Leeds, UK
- Chris Bojke
- Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
- Ivana Holloway
- Clinical Trials Research Unit (CTRU), University of Leeds, Leeds, UK
- David Phillip Alldred
- 1 School of Healthcare, University of Leeds, Leeds, UK
- Jonathan Silcock
- research assistant
- Lauren A Moreau
- Leeds Institute for Clinical Trials Research, Clinical Trials Research Unit, University of Leeds, Leeds, UK
- Bonnie Cundill
- Leeds Institute for Clinical Trials Research, Clinical Trials Research Unit, University of Leeds, Leeds, UK
- Alison Fergusson
- Leeds Institute for Clinical Trials Research, Clinical Trials Research Unit, University of Leeds, Leeds, UK
- Ellen Mason
- Leeds Institute for Clinical Trials Research, Clinical Trials Research Unit, University of Leeds, Leeds, UK
- DOI
- https://doi.org/10.1136/bmjopen-2021-054274
- Journal volume & issue
-
Vol. 12,
no. 4
Abstract
No abstracts available.